Bienville Capital Management, LLC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 168 filers reported holding CARDLYTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.

Quarter-by-quarter ownership
Bienville Capital Management, LLC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q4 2021$482,000
-21.2%
7,2900.0%0.35%
-0.3%
Q3 2021$612,000
-33.9%
7,2900.0%0.35%
+354.5%
Q2 2021$926,000
+15.8%
7,2900.0%0.08%
-23.8%
Q1 2021$800,000
-23.2%
7,2900.0%0.10%
-4.7%
Q4 2020$1,041,000
-84.3%
7,290
-92.2%
0.11%
-85.9%
Q3 2020$6,629,000
-51.1%
93,940
-51.5%
0.75%
-40.1%
Q2 2020$13,558,000193,7401.26%
Other shareholders
CARDLYTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Canaan Partners VIII LLC 1,133,141$29,439,00058.62%
Polaris Venture Management Co. V, L.L.C. 2,277,342$59,165,00046.48%
CAS Investment Partners, LLC 2,162,020$56,169,00014.39%
Cannell Capital 626,975$16,289,0004.62%
Antipodean Advisors LLC 142,358$3,698,0004.50%
Shannon River Fund Management LLC 344,230$8,943,0001.42%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 19,048$495,0001.40%
Tygh Capital Management, Inc. 176,237$4,579,0000.78%
Penn Capital Management Company, LLC 263,499$6,846,0000.68%
EAM Global Investors LLC 56,866$1,477,0000.63%
View complete list of CARDLYTICS INC shareholders